News | News By Subject | News by Disease News By Date | Search News

Angiogenesis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News

News from Around the Web
Gene That Reverses Blood Flow To Tumors Found by Western Australian Institute for Medical Research Researchers     4/17/2008
Protein Found That Helps Nerve Cells Cheat Death Without Unwanted Side Effects     2/13/2008
A New Significance Of LVD And Angiogenic MVD Is Identified In Human Primary SCRC     1/16/2008
University of California, Los Angeles (UCLA) Study Finds Blocking Angiogenesis Signaling from Inside Cell May Lead to Serious Health Problems     8/24/2007
The Importance of Angiogenesis     10/2/2006
Immunosuppression Transplant Drug Shown To Inhibit Angiogenesis In Cancerous Tumors     8/15/2006
Cancer Stem Cells Spur Glioma Angiogenesis, Could Hold Key To Brain Tumor Therapy     8/15/2006
Onyx Pharmaceuticals, Inc. (ONXX) Promising Cancer Drug     2/4/2005
Mechanism Found That "Protects" Aggressive Melanoma From Angiogenesis Inhibitors     10/13/2004
A Closer Look At Eyetech's Macugen     9/7/2004

Press Releases
ProMetic Life Sci (PFSCF.PK) Initiates Rolling Submission Of Its Biologics License Application ("BLA") For Plasminogen With U.S. FDA     12/19/2016
Hutchison Medipharma Starts Clinical Trial of Second Cancer Drug     2/1/2011
"Cancer Research" Journal Publishes Successful Angiogenesis Study Using Optimata Ltd.'s Technology     10/27/2008
Locus Pharmaceuticals, Inc. Initiates Strategic Inflammatory Cancer Research Collaborations     5/30/2008
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Authorized to Initiate Phase II Trial of Angiogenesis Therapy for Severe Coronary Heart Disease     7/10/2007
Vical Incorporated (VICL) Licensee AnGes MG Inc. Announces Positive Results of Phase 3 Angiogenesis Trial in Japan     6/18/2007
Lexicon Pharmaceuticals, Inc. (LEXG) Reports on Anti-Angiogenesis Target Discoveries     4/18/2007
OXiGENE (OXGN) Announces Publication In The Journal Science Of Results Showing Combination Therapy With Vascular Disrupting Agents (VDAs) And An Antiangiogenic Drug Markedly Suppresses Tumor Regrowth In An Animal Model     9/21/2006
MethylGene Updates On Multi-Targeted Kinase Inhibitor Program, Discloses Additional Anti-Angiogenic Targets     11/16/2005
Praecis Pharmaceuticals Incorporated (PRCS) Presents Preclinical Data On PPI-2458     9/21/2005
Dyax Corp. (DYAX) Announces Cancer Lead At Drug Discovery Conference; Positive Animal Model Results Using Dyax Antibody Against Tie-1     8/11/2005
TargeGen, Inc. Selects Lead Drug For Clinical Development As A Topical Treatment For Wet Macular Degeneration And Other Eye Diseases     7/29/2005
Cellular Genomics, Inc. Selects Drug Development Candidate In Proprietary Angiogenesis Inhibitor Program; Changes Corporate Name To CGI Pharmaceuticals     7/13/2005
U.S. Patent Office Grants Patent For Use Of GlycoGenesys, Inc. (Formerly SafeScience, Inc.)'s (GLGS) GCS-100 To Treat Angiogenesis-Related Diseases     6/1/2005
Intradigm Corporation's ICS-283: First Demonstration Of Clinically Viable, Systemically Administered RNA Interference Therapeutic Agent For Cancer And Ocular Angiogenesis     12/10/2004